02.05.2022 • NewsWuXi AppTecSingapore

Wuxi ATU Collaborates with Singapore’s BTI

WuXi Advanced Therapies (Wuxi ATU), US-based CDMO offshoot of WuXi AppTec, is joining up with Singapore’s Bioprocessing Technology Institute (BTI) to advance cell and gene therapy production in the Asia Pacific region.

Financial terms of the arrangement have not been disclosed.

The cooperation will focus on the Philadelphia, Pennsylvania-headquartered Wuxi arm’s Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) technology that improves adeno-associated virus (AAV) yields and particle quality. According to Wuxi, the platform produces significantly more AAV than plasmid-based manufacturing for cell and gene therapies.

Under the agreement, WuXi ATU will provide materials, equipment, funding and training to further develop and commercialize its technology. Singapore’s Bioprocessing Technology Institute will contribute its research expertise an facilities as well as affording access to its network of partners.

Koh Boon Tong, BTI’s executive director, called the collaboration “a significant step towards Singapore's goal to be an innovative biotherapeutics bioprocessing R&D hub.” 

Author: Dede Williams, Freelance Journalist

© Copyright 2020 WuXi AppTec. All Rights Reserved.
© Copyright 2020 WuXi AppTec. All Rights Reserved.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.